1. Home
  2. SCNI vs NAOV Comparison

SCNI vs NAOV Comparison

Compare SCNI & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.94

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Logo NanoVibronix Inc.

NAOV

NanoVibronix Inc.

HOLD

Current Price

$4.02

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCNI
NAOV
Founded
2003
2003
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCNI
NAOV
Price
$0.94
$4.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.7K
31.0K
Earning Date
11-24-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$1,147,000.00
$2,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.55
N/A
Revenue Growth
303.87
N/A
52 Week Low
$0.86
$3.55
52 Week High
$6.18
$162.50

Technical Indicators

Market Signals
Indicator
SCNI
NAOV
Relative Strength Index (RSI) 38.13 43.18
Support Level $1.14 $3.83
Resistance Level $1.26 $4.74
Average True Range (ATR) 0.10 0.45
MACD 0.02 0.07
Stochastic Oscillator 13.13 25.97

Price Performance

Historical Comparison
SCNI
NAOV

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Share on Social Networks: